In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 8, Pages 4043-4052
Publisher
Proceedings of the National Academy of Sciences
Online
2020-02-08
DOI
10.1073/pnas.1916039117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
- (2019) Susannah L. Hewitt et al. Science Translational Medicine
- In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia
- (2018) Zhi Cheng et al. MOLECULAR THERAPY
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Continuous microfluidic assembly of biodegradable poly(beta-amino ester)/DNA nanoparticles for enhanced gene delivery
- (2017) David R. Wilson et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma
- (2017) Camila G. Zamboni et al. JOURNAL OF CONTROLLED RELEASE
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs
- (2017) Chao Wang et al. Theranostics
- Nanovaccines for remodeling the suppressive tumor microenvironment: New horizons in cancer immunotherapy
- (2017) Kai Shi et al. Frontiers of Chemical Science and Engineering
- Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy
- (2016) Jayoung Kim et al. Acta Biomaterialia
- Advances in immunotherapy for melanoma
- (2016) Jason M. Redman et al. BMC Medicine
- Immune targets and neoantigens for cancer immunotherapy and precision medicine
- (2016) Rong-Fu Wang et al. CELL RESEARCH
- Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi-institutional retrospective study
- (2016) Yasuhiro Nakamura et al. JOURNAL OF DERMATOLOGY
- Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo
- (2015) Antonella Mangraviti et al. ACS Nano
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity
- (2015) Todd Bartkowiak et al. Frontiers in Oncology
- Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo
- (2014) Hugo Guerrero-Cázares et al. ACS Nano
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine
- (2014) Hui Yi Xue et al. Nanomedicine
- Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
- (2014) Loek J. Eggermont et al. TRENDS IN BIOTECHNOLOGY
- Synthetic virology: engineering viruses for gene delivery
- (2014) Caitlin M. Guenther et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts
- (2013) Stephany Y. Tzeng et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
- (2013) Jessica Ann Chacon et al. PLoS One
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
- (2010) Mingli Xu et al. Clinical & Developmental Immunology
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Emerging Toxicity Profiles of Anti–CTLA-4 Antibodies Across Clinical Indications
- (2010) Anna Maria Di Giacomo et al. SEMINARS IN ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More